Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIBP04 vs Bevacizumab in Advanced Non-squamous NSCLC
NCT05318443Phase 3Completed
- Sponsor
- Shanghai Institute of Biological Products
- Start
- Apr 2020
- Primary completion
- Dec 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of SIBP-04 in Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC), sponsored by Shanghai Institute of Biological Products. Started Apr 2020; status: completed.
02
Drugs
SIBP-04
03
Conditions
Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC)
Beyond the preview
Go deeper on NCT05318443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05318443.